General Information
Revision date
2020-09-07
Product name
Nifedipine Extended-Release Tablets 30 mg, 60 mg and 90 mg
CAS No.
21829-25-4
1.2.1 Relevant identified uses
Oral
Manufacturer Name
TWi Pharmaceuticals, Inc
Icons in SDS
Company Information
company name
TWi Pharmaceuticals, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
QA.Service@twipharma.com
GHS Information
Signal word
Warning
Section 2
2.1 Classification of the substance or mixture
Acute oral toxicity: Category 4 or Mixture:
Signal word
Warning
Hazard statements
Harmful if swallowed
Additional information
Short Term: Dust may cause irritation. May be harmful if swallowed. Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Exposure to sunlight following contact may result in skin reactions. Antihypertensive drug: has blood pressure lowering properties Fire and Explosion Hazards Not applicable. Known Clinical Effects Ingestion of this material may cause effects similar to those seen in clinical use including hypotension (low blood pressure), dizziness, headache and drowsiness. EU Indication of danger Not classified. Australian Hazard Non-Hazardous Substance. Non-Dangerous Goods.
Prevention
Wash face, hands and any exposed skin thoroughly after handling. Do not eat, drink or smoke when using this product Ingestion IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. Rinse mouth.
Disposal
Dispose of contents/container to an approved waste disposal plant. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
